Related Experiment Video
Updated: May 9, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment
Yukihiko Kawasaki1, Atsushi Ono, Shinichiro Ohara
1Department of Pediatrics, Fukushima Medical University School of Medicine, Japan. kyuki@fmu.ac.jp
Insights
Henoch-Schönlein purpura nephritis (HSPN) involves IgA immune complex deposition in the kidneys. Understanding its pathogenesis and prognostic factors is crucial for effective treatment strategies in children.
Area of Science:
- Immunology
- Nephrology
- Pediatrics
Background:
- Henoch-Schönlein purpura (HSP) is a systemic vasculitis characterized by IgA immune complex deposition.
- Renal involvement (HSPN) is a primary cause of morbidity and mortality in pediatric HSP cases.
- Clarifying HSPN pathogenesis, prognosis, and treatment is essential for improved patient outcomes.
Purpose of the Study:
- To review the current understanding of Henoch-Schönlein purpura nephritis (HSPN) pathogenesis.
- To identify key prognostic factors associated with HSPN.
- To summarize effective treatment strategies for severe HSPN.
Main Methods:
- Literature review of studies on HSPN pathogenesis, prognostic factors, and treatment.
- Analysis of proposed mechanisms involving galactose-deficient IgA1 (Gd-IgA1) and immune complex formation.
- Compilation of suggested prognostic indicators and outcomes of various therapeutic interventions.
Main Results:
- HSPN pathogenesis may involve Gd-IgA1 recognition by anti-glycan antibodies, leading to mesangial deposition and renal injury.
- Prognostic factors include nephrotic syndrome, hypertension, severe renal injury, and elevated myeloid-related protein levels.
- Aggressive therapies like combination drug therapy and plasmapheresis show efficacy in severe HSPN.
Conclusions:
- Further research into HSPN pathogenesis and well-designed randomized controlled trials in children are necessary.
- Identifying reliable prognostic factors can guide timely and appropriate management of HSPN.
- Optimizing treatment protocols is crucial for mitigating long-term renal damage in pediatric HSP.
Abstract:
Henoch-Schönlein purpura (HSP) is a systemic disorder characterized by leukocytoclastic vasculitis involving the capillaries and the deposition of IgA immune complexes. Renal involvement is the principal cause of morbidity and mortality in children with HSP. Thus, it is important to clarify the onset mechanism as well as the prognostic factors of Henoch-Schönlein purpura nephritis (HSPN) and to identify the most appropriate treatment. We herein review the pathogenesis, the prognostic factors and treatment of HSPN. As to the pathogenesis, several studies suggest that galactose-deficient IgA1 (Gd-IgA1) is recognized by anti-glycan antibodies, leading to the formation of circulating immune complexes and their mesangial deposition, thereby inducing renal injury. With regard to the prognostic factors, a number of factors have been suggested including nephrotic syndrome, decreased factor XIII activity, hypertension, severe renal injury, high renal accumulation of activated macrophage, alpha-smooth muscle actin, and high serum myeloid-related protein levels. For the treatment of severe HSPN, aggressive therapies including multiple drug combination therapy and plasmapheresis have been shown to be effective in ameliorating proteinuria and histological severity. Nevertheless, detailed investigation into the pathogenesis of HSPN and double-blind randomized control studies on children with HSPN are still necessary.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology
Acute Pyelonephritis I: Introduction
Chronic Kidney Disease I: Introduction
